Delivery Order 36C24E26D0008-36C24E26N0050
Award Date 3/2/26
Potential Completion Date 3/1/27
Potential Value $2.7M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60654, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Tempus Labs Inc. is providing tumor normal matched genomic testing services to the Department of Veterans Affairs (VA) under a $5,999,647 firm fixed price delivery order. This order was issued against an Indefinite Delivery contract held by Tempus with the VA worth up to $64 million for such services. Through January 2027, Tempus will analyze genomic sequencing data from veteran cancer patients' tumor and normal tissue samples to help inform precision medicine treatment decisions within the VA...
- The Department of Veterans Affairs (VA) Headquarters awarded a firm fixed price delivery order contract to Akesogen, Inc.'s Tempus Labs, Inc. division, a for-profit technology company that provides genomic sequencing and analysis services. The $13,020,379.40 contract tasks Tempus Labs with conducting genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services to support the VA's biomedical research programs,...
- This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Tempus AI, Inc. (doing business as Tempus Labs Inc.) for tumor normal matched genomic testing services. The contract has a ceiling value of $325,119.50 and a performance period through September 25, 2023. Tempus Labs is a technology company specializing in precision medicine and genomic sequencing services. This contract supports the VA's precision oncology initiatives for veteran cancer...
- The Department of Veterans Affairs Headquarters awarded Akesogen, Inc. Tempus Labs, Inc. Division, a for-profit organization, a Firm Fixed Price Delivery Order contract worth $9,874,980.00 to provide genomic analysis services. The contract, with a performance period ending March 20, 2024, tasks Tempus Labs with conducting genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services at the VA Headquarters in...
- The Department of Veterans Affairs (VA) awarded a $2,022,406 Firm Fixed Price Delivery Order contract to Tempus Labs Inc., doing business as Tempus, to provide Tumor Normal Matched Genomic Testing Services. Tempus will perform genomic testing services on tumor and normal tissue samples from VA patients to identify genomic variants that may be targeted for precision cancer therapies. The contract has a one-year period of performance starting January 28, 2022 through January 27, 2023 and will be...
- This federal contract award to Tempus AI, Inc. (doing business as Tempus Labs Inc.) is for tumor normal matched genomic testing services for the U.S. Department of Veterans Affairs (VA). The $5,718,045.00 firm fixed price delivery order contract, awarded on January 28, 2025, has a performance period extending through January 27, 2027. Tempus Labs Inc. is an experienced provider of genomic sequencing and precision medicine services to the VA, holding a larger $64,296,441.00 Indefinite Delivery...
- This federal contract award is for TUMOR NORMAL MATCHED GENOMIC TESTING SERVICES, awarded by the U.S. Department of Veterans Affairs (VA) to Tempus AI, Inc., doing business as Tempus Labs Inc. The contract has a ceiling value of $7,989,504.00 and is a firm fixed price delivery order with a performance period through January 27, 2024. Tempus Labs Inc. is the prime contractor and specializes in precision medicine and genomic sequencing services. The company has established itself as a key provider...
- Modification P9 to an Indefinite Delivery Contract established a delivery order valued at approximately $5.3 million awarded to Tempus AI, Inc. (doing business as Tempus Labs Inc.) by a civilian federal agency headquartered in Washington, D.C. This firm fixed price delivery order, with an ultimate completion date of January 27, 2027, represents work under a larger $64.3 million IDC with the Department of Veterans Affairs that was originally awarded on January 28, 2022. The modification updates...
- This is a $4,000,000.00 firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs Headquarters to Akesogen, Inc.'s Tempus Labs, Inc. division for genomic analysis services. The contract has a period of performance through July 21, 2025 and is not designated as a set-aside. Tempus Labs, a for-profit technology company, will provide genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular...
- The Department of Veterans Affairs Veterans Integrated Service Network 7 awarded a $66,869 firm fixed-price purchase order to Tempus AI, Inc. (doing business as Tempus Labs Inc.) on September 30, 2024, for DNA methylation and genome-wide association study services. The contract supports a research initiative evaluating epigenetic aging changes in HIV-positive veterans who participated in a telehealth-delivered high-intensity exercise study. The work will be performed in Chicago, Illinois, and...